|
Market Closed -
Oslo Bors
10:45:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 4.510 NOK | +10.00% |
|
+33.23% | +86.98% |
| 08-20 | Nykode Therapeutics Wins New US Patent for Neoantigen-based Cancer Vaccine | MT |
| 08-06 | Nykode Therapeutics Asa Announces Appointment of Jakob Helding Rasmussen as Chief Technology Officer | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- VACC Stock
- Consensus Nykode Therapeutics
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
